Ignite Creation Date:
2024-05-05 @ 4:47 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00311155
Status:
COMPLETED
Last Update Posted:
2010-12-10
First Post:
2006-04-03
Brief Title:
Olmesartan and an add-on Treatment in Patients With Mild to Moderate Hypertension
Sponsor:
Sankyo Pharma Gmbh
Organization:
Daiichi Sankyo
Study Overview
Official Title:
Treat-to-Target Study of Olmesartan Medoxomil and an Add-on Treatment Algorithm Consisting of Hydrochlorothiazide and Amlodipine Besylate in Patients With Mild to Moderate Hypertension
Status:
COMPLETED
Status Verified Date:
2010-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
OLMETREAT
Brief Summary:
This study is to assess the safety and efficacy of an add-on treatment algorithm with olmesartan hydrochlorothiazide and amlodipine in patients with mild to moderate hypertension
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2005-004659-36 | EUDRACT_NUMBER | None | None |